logo

A Closer Look at Adaptimmune Therapeutics Plc ADR (ADAP) Stock Gains

PNC Stock

Adaptimmune Therapeutics Plc ADR experienced a rather shaky stock market performance. The highest value in the past year was recorded at $2.05 on 03/08/24 and the lowest value was $0.42 on 11/28/23.

52-week price history of ADAP Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Adaptimmune Therapeutics Plc ADR’s current trading price is -52.36% away from its 52-week high, while its distance from the 52-week low is 132.55%. The stock’s price range during the 52-week period has remained between $0.42 and $2.05. In the Healthcare sector, the company’s shares saw a trading volume of around 1.48 million for the day, which was evidently lower than the average daily volume of 1.99 million over the past three months.

Market Capitalization and Financial Performance: An In-Depth Look

Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly rise of 39.01% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 221.88M and boasts a workforce of 449 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.0478, with a change in price of +0.5117. Similarly, Adaptimmune Therapeutics Plc ADR recorded 1,550,785 in trading volume during the last 100 days, posting a change of +110.04%.

Examining ADAP’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ADAP stands at 0.64. Similarly, the long-term debt-to-equity ratio is also 0.50.

ADAP Stock Stochastic Average

As of today, Adaptimmune Therapeutics Plc ADR’s raw stochastic average for the last 50 days stands at 8.88%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 13.45%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 8.24% and 7.18%, respectively.

ADAP Stock Price Performance Analysis

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. The index has shown a price gain of 23.17% this year. Over the last six months, there has been a weaker performance of 66.45%. The price of ADAP leaped by -26.56% during the last 30 days period. For the last 5-days stocks have slided -15.80%.